Showing results (301-310 of 408) with videos related to

Sort By:
Pageof 41
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2019
Clinical Implications of Microbiologic Treatment Failure in the Setting of Clinical Cure of Bacterial PneumoniaOwen R Albin, Oryan Henig, Twisha S Patel, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 1, 2024
A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumoniaOwen R Albin, Jonathan P Troost, Louis Saravolatz, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2016
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like CarbapenemaseM Earth Hasassri, Thomas G Boyce, Andrew P Norgan, et al.
Infection Control and Hospital Epidemiology|November 25, 2014
Prevalence of and risk factors for vancomycin-resistant Staphylococcus aureus precursor organisms in Southeastern MichiganValerie S Albrecht, Marcus J Zervos, Keith S Kaye, et al.
Antibiotics (Basel, Switzerland)|August 6, 2021
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumanniiJacinda C Abdul-Mutakabbir, Juwon Yim, Logan Nguyen, et al.
American Journal of Epidemiology|February 19, 2005
Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organismsJessina C McGregor, Peter W Kim, Eli N Perencevich, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2025
A mechanism-based pharmacokinetic/pharmacodynamic analysis of polymyxin B-based combination therapy against carbapenem-resistant Klebsiella pneumoniae isolates with diverse phenotypic and genotypic resistance mechanismsRamya Mahadevan, Estefany Garcia, Rajnikant Sharma, et al.
American Journal of Infection Control|May 20, 2014
Understanding health care personnel's attitudes toward mandatory influenza vaccinationReda A Awali, Preethy S Samuel, Bharat Marwaha, et al.
Eclinicalmedicine|December 4, 2025
Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trialThomas M File, Keith S Kaye, Skliarov Ihor, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2018
Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing EnterobacteriaceaeKrisztina M Papp-Wallace, Melissa D Barnes, Jim Alsop, et al.
Pageof 41